Peer Review History
| Original SubmissionNovember 8, 2022 |
|---|
|
PONE-D-22-30835Antibiotic perceptions, adherence, and disposal practices among parents of pediatric patients: a mixed-methods studyPLOS ONE Dear Dr. Dantuluri, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. If you feel any points raised by the reviewers may not be relevant to your manuscript do explain with your reasons. Kindly use the COREQ checklist for reporting the qualitative findings. You can show how you have met or not met the different parameters in a separate table. Please submit your revised manuscript by Jan 20 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Pathiyil Ravi Shankar Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "Dr. Dantuluri was supported by a NIAID grant T32A1095202 (PI: Mark Denison) and the Vanderbilt University Trans-Institutional Programs (TIPS) Vanderbilt Study of Antimicrobial Resistance (V-StAR) (Co-PIs: Leigh Howard and Carlos Grijalva). Dr. Grijalva was supported in part by NIAID grant 1K24AI148459-01. Dr. Howard was supported in part by NIAID grant K23AI141621. JMP acknowledges salary support from NIH K01MH115811. We thank the Vanderbilt Pediatric Outpatient Clinic for assistance with the investigation." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "KLD was supported by a NIAID grant T32A1095202 (PI: Mark Denison) and the Vanderbilt University Trans-Institutional Programs (TIPS) Vanderbilt Study of Antimicrobial Resistance (V-StAR) (Co-PIs: Leigh Howard and Carlos Grijalva). CGG was supported in part by NIAID grant 1K24AI148459-01. LMH was supported in part by NIAID grant K23AI141621. JMP acknowledges salary support from NIH K01MH115811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: No Reviewer #5: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes Reviewer #3: N/A Reviewer #4: No Reviewer #5: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: No Reviewer #5: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study is relevant to the current clinical scenario. However the sample size is too small to derive any statistical output and make conclusion. There are some challenges which are noticed in the manuscript which may require serious attention: 1.There are minor grammatical error at the following lines: 52,53,70,74 2. The sample size is too small to make any conclusion . This makes your research output weak and non conclusive as your data also includes quantitative data not only qualitative data. You could look at increasing your sample size for quantitative data. 3. In the demographic details there is no mention of males patients 4. The qualitative aspect of the methodology is clearly explained. However, the quantitative methodology is not clearly explained in the manuscript which need further elaboration eg: the scales used for the questionnaire. 5. Why was the qualitative data collected via interview and not self-administered considering that the respondents had basic education 6. We see that most of the respondents were unmarried women, wouldn't that be a bias and affect your results? Any reason for this finding? Reviewer #2: This is a nice qualitative manuscript evaluating parent's perceptions about antibiotic use, adherence, and disposal practices among pediatric patients with respiratory tract infections. The authors interviewed 13 parents of young children who received antibiotics. Almost all of them were for acute otitis media. The parents provided a variety of responses about how antibiotics worked and plans for disposal. The interviews were then transcribed and coded using qualitative software. The analysis appears robust the conclusions sound. The authors did a nice literature review supporting that several of their findings were similar to surveys. The manuscript is also well written. I only have a few comments for the authors. 1) Why did you choose the ages of 2-5? I assume that this is because it was part of a larger study. If this is the case, please include that detail. 2) You only interviewed children who received antibiotics, and this was almost entirely for acute otitis media. Patients perceptions about antibiotics and how they work may be different for parents who receive antibiotics vs. those that did not. This should be considered in the limitations section. 3) I think the disposing of medications is really fascinating. The authors highlight a lot of limitations about disposing them e.g., pharmacies also giving bad advice, lack of takeback locations etc. Can the authors describe any potential pragmatic solutions for people who may want to work on this issue? 4) The demographics skew very much towards unmarried mothers with low incomes who are minorities. This should also be highlighted. I am not sure if the results would look different with other populations. If you suspect that they are the same regardless of demographics, I would also state that and describe why. Reviewer #3: Thank you very much for the invitation to review the manuscript entitled “Antibiotic perceptions, adherence, and disposal practices among parents of pediatric patients: a mixed-methods study”. I think this is a well-conducted study and a well-written manuscript. In addition, the study addresses an important topic on the rational use of antibiotics from the patients’ perspectives. For further improvement, I have the following comments: 1. On page 4, line 65, I think the authors could edit the beginning of the 3rd paragraph of the introduction. This is because it starts with “Third, ” as a continuation of the idea addressed in the 2nd paragraph, i.e., the interconnected processes influencing antibiotic use. 2. On page 6, line 104, please spell out ARI as this is the first time mentioned in the manuscript. 3. On page 7, line 123, please add a reference to REDCap. This is because some readers might not be familiar with this tool/software, i.e., https://projectredcap.org/ 4. On page 7, line 115, please explain how thematic saturation is defined in this study, and please support with (a)reference(s). 5. On page 11, line 182, please indicate that Q stands for a quote. This is to ensure this abbreviation is clear for all the readers. 6. I think the discussion could be further enhanced with more comparisons with the literature. 7. In the title, the authors stated that this is “a mixed-methods study”. In the abstract (page 3, line 35), the authors stated “we conducted a qualitative study”. In addition, the methods section is focused on the qualitative study. I feel this is mainly a qualitative study using semi-structured interviews. The quantitative part with the same 13 participants (i.e. closed-ended questions in S2 Table) is to complement the major qualitative part. Consequently, what about editing this in the title to better reflect the study design? Thank you and all the best. Reviewer #4: It is an important topic on Antibiotic perceptions, adherence, and disposal practices among parents of pediatric patients. Introduction: English: to be improved Material and Methods: Where the study was conducted? urban outpatient clinic? Please mention about the location/state. NVivo software was used data analysis? As the data is mostly qualitative. Sentence no. 139 and 140 suggests that the transcripts and coded quotes were managed using Microsoft Excel (version 2016) and SPSS (version 26)? Why the sample size was 13? How was the sample selected? Whether the interviews were conducted till data saturation? Results Table 1: What does 163 and 164 suggests? Only 2 antibiotics were prescribed? Clindamycin and Amoxicillin. Discussion Line no. 264- Be more specific. Which study the authors are referring to? 268- It is better to avoid Another survey. Please refer to the study. Reviewer #5: Good points 1. The introduction is appropriate. 2. The Inclusion and Exclusion criteria have been appropriately included. 3. Pilot testing was done and consent was taken .Semi structured interviews with audio recording was a good idea. 4. Quantitative data was transcribed by the professionals and this was again a good idea. Please explain and make amends accordingly 1. Why was a gift coupon worth $35, given to the participants? This seems to be unethical. 2. Sample size seems to be too small. How did you determine the sample size and what were your limitations? 3. Please mention what additional information you could derive from the structured interviews, besides that obtained from the questionnaire. Was data saturation taken into consideration when piloting the questionnaire? Did questionnaire planning precede the interview? 4. Reference 11, Page number missing. 5. What was the need for the team members to meet when decoding the interview transcripts? Could it have given rise to some bias and how did you take care of the investigators bias. Other Points: 1. Title page missing 2. Table caption can be added. 3. Funding acknowledgement not to be done anywhere in the manuscript .Please check if salary support is a funding acknowledgement. 7. Would you like your identity revealed to the authors of this submission? Answer: No 8. Do you have any potentially competing interests? Answer: "None." 9. Do you want to get recognition for this review on Publons Answer: No ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Michael Durkin Reviewer #3: No Reviewer #4: Yes: Dr. Indrajit Banerjee Reviewer #5: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Antibiotic perceptions, adherence, and disposal practices among parents of pediatric patients PONE-D-22-30835R1 Dear Dr. Dantuluri, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Pathiyil Ravi Shankar Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #5: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: There are no more suggestions to be made .All the suggestions made to improve the manuscript has been addressed. All the best. Reviewer #2: (No Response) Reviewer #3: Thank you very much for addressing my comments on the earlier version. I think the revised version is now OK. I wish you all the best. Reviewer #5: There wee a few queries that I had raised earlier. The authors have answered the queries satisfactorily.The paper may be accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Michael Durkin Reviewer #3: No Reviewer #5: Yes: Dr Juhi Kalra ********** |
| Formally Accepted |
|
PONE-D-22-30835R1 Antibiotic perceptions, adherence, and disposal practices among parents of pediatric patients Dear Dr. Dantuluri: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Pathiyil Ravi Shankar Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .